683 Capital Management, LLC - Q2 2018 holdings

$1.48 Billion is the total value of 683 Capital Management, LLC's 150 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 59.1% .

 Value Shares↓ Weighting
KO SellCOCA COLA COput$26,316,000
-13.4%
600,000
-14.3%
1.78%
-33.8%
PCG SellPG&E CORP$25,192,000
-31.9%
591,910
-29.7%
1.70%
-47.9%
MMM Sell3M COput$19,770,000
-67.3%
100,500
-63.5%
1.34%
-75.0%
ENVA SellENOVA INTL INC$19,424,000
+40.4%
531,449
-15.3%
1.31%
+7.4%
JNJ SellJOHNSON & JOHNSONput$14,561,000
-9.1%
120,000
-4.0%
0.98%
-30.5%
XHR SellXENIA HOTELS & RESORTS INC$13,398,000
-6.3%
550,000
-24.1%
0.90%
-28.3%
CRESY SellCRESUD S A C I F Y Asponsored adr$10,100,000
-36.7%
681,500
-13.9%
0.68%
-51.6%
FATE SellFATE THERAPEUTICS INC$8,437,000
-13.0%
744,011
-25.1%
0.57%
-33.5%
ETSY SellETSY INC$7,383,000
-45.7%
175,000
-63.9%
0.50%
-58.5%
HCC SellWARRIOR MET COAL INC$6,203,000
-26.2%
225,000
-25.0%
0.42%
-43.6%
XLP SellSELECT SECTOR SPDR TRput$5,153,000
-51.0%
100,000
-50.0%
0.35%
-62.6%
CFRX SellCONTRAFECT CORP$5,138,000
+26.5%
2,324,836
-7.0%
0.35%
-3.3%
SMPLW SellSIMPLY GOOD FOODS CO*w exp 07/07/202$3,318,000
-15.1%
799,459
-0.1%
0.22%
-35.1%
LTRPA SellLIBERTY TRIPADVISOR HLDGS IN$2,013,000
-6.4%
125,000
-37.5%
0.14%
-28.4%
VBLT SellVASCULAR BIOGENICS LTD$762,000
-17.2%
346,574
-13.4%
0.05%
-37.0%
EACQW SellEASTERLY ACQUISITION CORP*w exp 07/29/202$625,000
-21.7%
500,000
-47.4%
0.04%
-40.8%
WMGIZ SellWRIGHT MED GROUP N Vright 03/01/2019$517,000
-53.9%
403,531
-50.7%
0.04%
-64.6%
TDWWSB SellTIDEWATER INC NEW*w exp 07/31/202$39,000
-92.3%
14,178
-76.7%
0.00%
-93.3%
PLXP ExitPLX PHARMA INC$0-21,660
-100.0%
-0.01%
ONTXW ExitONCONOVA THERAPEUTICS INC*w exp 07/11/202$0-2,000,000
-100.0%
-0.02%
ELECW ExitELECTRUM SPL ACQUISITION COR*w exp 06/16/202$0-666,200
-100.0%
-0.02%
SLNOW ExitSOLENO THERAPEUTICS INC*w exp 11/12/201$0-602,443
-100.0%
-0.02%
CVONW ExitCONVERGEONE HLDGS INC*w exp 04/12/202$0-401,806
-100.0%
-0.04%
MTEC ExitMTECH ACQUISITION CORP$0-75,000
-100.0%
-0.06%
RGNX ExitREGENXBIO INC$0-25,000
-100.0%
-0.07%
DRNA ExitDICERNA PHARMACEUTICALS INC$0-125,000
-100.0%
-0.11%
HIIQ ExitHEALTH INS INNOVATIONS INC$0-50,000
-100.0%
-0.13%
OPESU ExitOPES ACQUISITION CORPunit 03/07/2023$0-150,000
-100.0%
-0.13%
CMSS ExitCM SEVEN STAR ACQUISITION CO$0-175,000
-100.0%
-0.15%
CNAC ExitCONSTELLATION ALPHA CAP CORP$0-180,000
-100.0%
-0.16%
LTNU ExitUNION ACQUISITION CORPunit 99/99/9999$0-200,000
-100.0%
-0.18%
CVNA ExitCARVANA COcall$0-93,700
-100.0%
-0.19%
CISNWS ExitCISION LTD*w exp 06/22/202$0-1,530,000
-100.0%
-0.32%
MDLZ ExitMONDELEZ INTL INCput$0-100,000
-100.0%
-0.37%
SATS ExitECHOSTAR CORPcl a$0-80,000
-100.0%
-0.37%
TIBRU ExitTIBERIUS ACQUISITION CORPunit 02/28/2021$0-450,000
-100.0%
-0.40%
WMT ExitWALMART INCput$0-75,000
-100.0%
-0.59%
XLE ExitSELECT SECTOR SPDR TRput$0-100,000
-100.0%
-0.60%
IBM ExitINTERNATIONAL BUSINESS MACHSput$0-50,000
-100.0%
-0.68%
XLU ExitSELECT SECTOR SPDR TRput$0-200,000
-100.0%
-0.89%
KKR ExitKKR & CO L P DEL$0-550,000
-100.0%
-0.99%
FOGO ExitFOGO DE CHAO INC$0-950,000
-100.0%
-1.32%
BTU ExitPEABODY ENERGY CORP NEW$0-417,566
-100.0%
-1.35%
TWX ExitTIME WARNER INC$0-200,000
-100.0%
-1.67%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2018-09-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IRSA INVERSIONES Y REP S A42Q3 20232.9%
CRESUD S A C I F Y A42Q2 20243.3%
ENOVA INTL INC36Q1 20248.2%
UNIQURE NV31Q2 20244.1%
INSPIRED ENTMT INC31Q2 20242.3%
CARVANA CO27Q2 202414.2%
FENNEC PHARMACEUTICALS INC27Q1 20240.9%
MICRON TECHNOLOGY INC26Q1 20233.2%
GALMED PHARMACEUTICALS LTD25Q1 20201.2%
ALNYLAM PHARMACEUTICALS INC24Q2 20223.2%

View 683 Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

View 683 Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
SC 13G2024-06-24
13F-HR2024-05-15
SC 13G2024-03-01
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View 683 Capital Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export 683 Capital Management, LLC's holdings